Regeneron Pharma (REGN) PT Lowered to $810 at Guggenheim
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $846.29 -0.67%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 22
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 22
Join SI Premium – FREE
Guggenheim analyst Yatin Suneja lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $810.00 (from $940.00) while maintaining a Buy rating.
You May Also Be Interested In
- RBC Capital Reiterates Sector Perform Rating on Regeneron Pharma (REGN)
- Dycom Industries (DY) PT Lowered to $375 at Raymond James
- Climb Bio (CLYM) PT Raised to $25 at Baird
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
